SYMATESE Accelerates Global Expansion: Ambitious Growth Strategy

SYMATESE announces the commercial Launch of Evolysse™ in the US

SYMATESE Secures FDA Approval for EVOLYSSE™

SYMATESE previews COLD-X™ TECHNOLOGY at IMCAS

SYMATESE DEVICE invites you to Pharmapack 2025

SYMATESE reaches a decisive milestone!

SYMATESE Announces Submission to U.S. FDA for its Pre-market approval Application for its HA dermal fillers

SYMATESE DEVICE at “The Pharma Days” in Geneva

Lacrifill®: a new dry eye treatment by Nordic Pharma

SYMATESE celebrates 10 years with NEVELIA®

SYMATESE launches SYMATESE LAB

1st class III product under MDR CE marking